Clonal hematopoiesis and acquired genetic abnormalities of the red cell: An historical review.
Blood cell antigens
Hemolytic anemia
Myelodysplasia
Myeloid neoplasms
Porphyria
Red cell enzymes
Red cell membranes
Red cells
Somatic mutations
Thalassemia
Journal
Blood cells, molecules & diseases
ISSN: 1096-0961
Titre abrégé: Blood Cells Mol Dis
Pays: United States
ID NLM: 9509932
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
received:
22
10
2023
accepted:
02
11
2023
medline:
6
12
2023
pubmed:
12
11
2023
entrez:
11
11
2023
Statut:
ppublish
Résumé
Several syndromes affecting the red cell that mimic those induced by germline mutations may result from a somatic mutation that accompanies a myeloid malignancy. These syndromes are most notable in cases of myelodysplastic syndrome, but they are not limited to any one category of myeloid neoplasm. Their occurrence in males exceed the male predominance that is evident in myeloid neoplasms. The syndromes include disorders of globin chain synthesis (α- and β-thalassemia), heme synthesis (erythropoietic porphyria and erythropoietic uroporphyria), red cell membrane structure (elliptocytosis and spherocytosis), red cell enzyme activity (pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency) and lowered expression of red cell ABO blood group antigens. This historical review describes the path to uncovering these acquired syndromes and their causal somatic mutations, where known. These syndromes often go unrecognized because of the dominant concern of the primary neoplasm. They may add to the healthcare needs of the patient.
Identifiants
pubmed: 37951089
pii: S1079-9796(23)00078-5
doi: 10.1016/j.bcmd.2023.102801
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102801Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The author has no competing interests. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Artificial intelligence was not used for composition.